FDA NDC Directory · JSON-LD · Markdown

Theophylline

NDC 71321-502 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerBrandywine Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA087400
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTHEOPHYLLINE ANHYDROUS (300 mg/1)
Marketing started20250930
Package count1

External sources

Source: openFDA. Public-domain (CC0).